You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

Biovet AD

Summary

Company ID (NIN)

112029879

Company owner / manager

  • Huvepharma AD
  • Other

Country

Bulgaria

Capital

6,783,000

Total assets

639,045,000

Net profit for the period

28,857,000

Report year

2018

Currency

BGN

Industry

Pharmaceuticals

Southeastern Europe Company Index (SEECI)

What is SEECI?

General information

About Biovet AD

Biovet AD is a Bulgarian veterinary medicine producer. The company manufactures antibiotic feed additives and veterinary pharmaceuticals.

The company holds the following valid certificates:

  • ISO 9001:2008 Quality management systems certificate;
  • OHSAS 18001:2007 Occupational health and safety management systems certificate.

Biovet AD`s products comply with the requirements of the European, British and United States Pharmacopoeia standards.

Since 2014, the company is GMP certified by the Bulgarian Institute for Control of Veterinary Medicinal Products.

 

Last updated on Nov 8, 2019.

Meta info
Status
Active
Legal form
Joint Stock Company
Incorporation date
Jan. 9, 1961
NIN
112029879
Tickers
Stock Exchange
ISIN
Profile last updated
Nov. 8, 2019, 1:40 p.m.
Alternative names

    Biovet JSC
    Biovet PLC

History

    Jan 9, 1961 - Zavod za Microbialni Preparati is established.

    Nov 22, 1991 – It restructures and renames to Biovet.

    Apr 16, 1996 - Biovet increases its subscribed capital to BGL 969.054 mln from BGL 51.720 mln and transforms into a joint stock company.

    1998 – The company lists on the Bulgarian Stock Exchange.

    Nov 27, 1998 – The Bulgarian Privatisation Agency announces its plans to sell 54% in Biovet AD to the USA-based company ICN Pharmaceuticals Inc., for USD 13.6 mln, after a tender.

    Apr 7, 1999 - ICN Pharmaceuticals Inc. rejects the contract due to the NATO's bombing campaign in Kosovo.

    Apr 24, 2000 – The Bulgarian Privatisation Agency sells 54% in Biovet AD to the Bulgarian Pharmaceutical Company (BPC) for USD 10.639 mln in cash.

    2001 – Biovet AD establishes a retail and marketing subsidiary Biovet Europe SRL in Italy.

    2002 – The company acquires a plant for the production of enzymes in Botevgrad, western Bulgaria.

    June 22, 2005 – Biovet AD opens a branch in Razgrad, northeastern Bulgaria.

    July 22, 2005 – The company buys veterinary drug production companies, which are owned by Iceland-based generic drug company Actavis, in Bulgaria and Macedonia. The company changes the name of its Macedonian factory to Biovet Macedonia OOD. The Bulgarian Competition Protection Commission allows Biovet AD to acquire part of Actavis' long-term assets for the production and sale of veterinary products located in Razgrad, northeastern Bulgaria.

    July 18, 2005 – Biovet AD majority shareholder, Bulgarian Pharmaceutical Company, renames to Huvepharma.

    July 29, 2005 – The company buys part of the feed additives business of animal healthcare firm Intervet international B.V., a part of Dutch chemical group Akzo Nobel, for EUR 22.5 mln. Biovet AD's shareholders approve the deal at an extraordinary meeting on July 15, 2005.

    April 2016 - Biovet AD sets up its wholly owned subsidiary biotechnological researcher Abio EOOD.

    2017 - The company establishes majority owned subsidiary BioTechIno OOD, active in biotechnological research activities, in which it holds 50.8%.

    Mar 27, 2017 - Biovet AD delists from the Bulgarian Stock Exchange (Stock Symbol: 53B, ISIN: BG11BIPEAT11).

    2018 - The company sets up its wholly owned energy trading company Stock Energy EOOD. Biovet AD acquires 60% in Ukrainian Evroline 2018 LLC.

     

    Last updated on Nov 8, 2019.

Management

Supervisory Board
Daniela Lyubchova Deshova
Member of the Board
Kiril Petrov Domuschiev
Chairman of the Board
Irena Stoyanova Kumanova
Deputy-Chairman of the Board
Board of Directors and Executives
Spas Bozhidarov Petkov
Member of the Board
Nadezhda Ilieva Petkova
Member of the Board
Ivan Dimitrov Michev
Member of the Board
Angel Zhelyazkov Ivanov
Chairman of the Board and CEO
Temenuga Ivanova Gazdova
Member of the Board

Contacts

Address
39, Petar Rakov Str.
4550
Peshtera, Bulgaria
Telephones

+359 350 65 619
+359 350 65 637
+359 350 65 634
+359 350 65 635

Fax

+359 350 56 607
+359 350 65 636

Emails

biovet@biovet.com
salesdept@biovet.com
mts@biovet.com

Websites
www.biovet.com

Ownership

Name Direct holding Indirect holding Owner type Country
Huvepharma AD 95.54 Company Bulgaria
Other 4.46 Other

Subsidiaries and affiliates

Name Direct holding Indirect holding Country
Abio EOOD 100.0 Bulgaria
BioTechIno OOD 50.8 Bulgaria
Stock Energy EOOD 100.0 Bulgaria
Evroline 2018 LLC 60.0 Ukraine
Biovet Macedonia EOOD 100.0 N. Macedonia

Products and services

Biovet AD produces and retails:

  • animal health products:
    • anti-infectives;
    • growth promoters;
    • anticoccidials;
  • active pharmaceutical substances;
  • enzymes and food additives;
  • crop protection products.

The company`s products are made in different forms, including powder and granulated, injectables, tablets and capsules.

Biovet AD offers more than 50 bulk substances and finished dosage forms.

Capacity

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Employment

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Market and sales

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Investment plans

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Financial information

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles
Compare